Sentri7 earns Category Leader designation for Clinical Decision Support-Surveillance in the 2015/2016 Best in KLAS Report

The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that its Sentri7 solution has received the 2015/2016 Category Leader award for Clinical Decision Support-Surveillance in the 2015/2016 Best in KLAS: Software & Services report. The real-time clinical surveillance and decision support software previously earned the Category Leader designation in KLAS’ 2013 Best in KLAS report, which is conducted annually to rank the best-performing healthcare IT vendors in more than 100 market segments based on the aggregated experiences of thousands of healthcare providers.

KLAS research enables providers to make more-informed technology decisions and helps vendors strive for excellence. An independent healthcare IT vendor research firm, KLAS publishes the annual Best in KLAS report to provide healthcare organizations with an unbiased and accurate vehicle for measuring performance in the healthcare industry, allowing for further understanding of how well suppliers and products perform.

“Real-time clinical surveillance systems are integral to success in today’s performance- and value-based healthcare environment,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “We designed Sentri7 to help hospitals achieve the over-arching objectives of higher quality, lower cost care, and to help clinicians by speeding identification of risk and treatment decisions. We are honored to have our customers once again acknowledge through KLAS the role Sentri7 plays in helping them achieve these objectives.”

Tags: , , ,

Trackback from your site.

Leave a comment

You must be logged in to post a comment.

Get our eNewsletter

Email Marketing powered by StreamSend

Please follow & like us :)

RSS
Follow by Email
Facebook
Google+
https://us.hitleaders.news/sentri7-earns-category-leader-designation-for-clinical-decision-support-surveillance-in-the-20152016-best-in-klas-report/">
Twitter